316 related articles for article (PubMed ID: 16440205)
41. Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome.
Zhu GF; Sun B; Niu SF; Cai YY; Lin K; Lindwall R; Robertson B
Am J Respir Crit Care Med; 1998 Aug; 158(2):437-43. PubMed ID: 9700118
[TBL] [Abstract][Full Text] [Related]
42. Surfactants in Acute Respiratory Distress Syndrome in Infants and Children: Past, Present and Future.
Amigoni A; Pettenazzo A; Stritoni V; Circelli M
Clin Drug Investig; 2017 Aug; 37(8):729-736. PubMed ID: 28510235
[TBL] [Abstract][Full Text] [Related]
43. [Bases of the replacement surfactant therapy for bronchopulmonary diseases].
Zagorul'ko AK; Kliaritskaia IL
Lik Sprava; 2004; (5-6):79-86. PubMed ID: 15605831
[TBL] [Abstract][Full Text] [Related]
44. [Critical state medicine. Surfactant therapy of adult respiratory distress syndrome (results of multicenter studies)].
Granov AM; Rozenberg OA; Tsybul'kin EK; Erokhin VV; Khubulava GG; Likhvantsev VV; Osovskikh VV; Bautin AE; Gavrilin SV; Kazennov VV; Zhilin IuN; Nabokova TS; Shefer SP; Vashkevich SM; Nefedov AV; Seĭliev AA; Volchkov VA
Vestn Ross Akad Med Nauk; 2001; (5):34-8. PubMed ID: 11510148
[TBL] [Abstract][Full Text] [Related]
45. Consensus on surfactant and inhaled nitric oxide for ARDS.
Gadek JE
J Aerosol Med; 1996; 9(1):155-62. PubMed ID: 10160205
[TBL] [Abstract][Full Text] [Related]
46. Surfactant replacement therapy in ARDS: white knight or noise in the system?
Nicholas TE; Doyle IR; Bersten AD
Thorax; 1997 Feb; 52(2):195-7. PubMed ID: 9059486
[TBL] [Abstract][Full Text] [Related]
47. Surfactant treatment for congenital heart disease patients with acute respiratory distress syndrome.
Alten JA; Borasino S; Pearce FB; Dabal RJ; Kirklin JK
Congenit Heart Dis; 2010; 5(6):624-8. PubMed ID: 21106025
[TBL] [Abstract][Full Text] [Related]
48. [Natural surfactant preparation in complex therapy of acute respiratory distress syndrome in adults following open-heart surgeries].
Bautin AE; Khubulava GG; Osovskikh VV; Rozenberg OA
Anesteziol Reanimatol; 2003; (4):55-7. PubMed ID: 14524023
[TBL] [Abstract][Full Text] [Related]
49. 99mTc-DTPA-surfactant inhalation in adult respiratory distress syndrome (ARDS): a new diagnostic-therapeutic tool.
Todisco T; Cosmi E; Dottorini M; Baglioni S; Eslami A; Fedeli L; Palumbo R
J Aerosol Med; 1992; 5(2):113-22. PubMed ID: 10147686
[TBL] [Abstract][Full Text] [Related]
50. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.
Markart P; Ruppert C; Wygrecka M; Colaris T; Dahal B; Walmrath D; Harbach H; Wilhelm J; Seeger W; Schmidt R; Guenther A
Thorax; 2007 Jul; 62(7):588-94. PubMed ID: 17287298
[TBL] [Abstract][Full Text] [Related]
51. Restoring pulmonary surfactant membranes and films at the respiratory surface.
Echaide M; Autilio C; Arroyo R; Perez-Gil J
Biochim Biophys Acta Biomembr; 2017 Sep; 1859(9 Pt B):1725-1739. PubMed ID: 28341439
[TBL] [Abstract][Full Text] [Related]
52. Surfactant therapy in infants and children: three years experience in a pediatric intensive care unit.
Hermon MM; Golej J; Burda G; Boigner H; Stoll E; Vergesslich K; Strohmaier W; Pollak A; Trittenwein G
Shock; 2002 Apr; 17(4):247-51. PubMed ID: 11954821
[TBL] [Abstract][Full Text] [Related]
53. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J; Speer CP
J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
[TBL] [Abstract][Full Text] [Related]
54. [The pulmonary surfactant system: physiology, pathologies associated with its alteration and exogenous administration as therapeutic and diagnostic agent].
Calmanovici G; Boccio J; Lysionek A; Salgueiro M; Caro R; Hager A; de Paoli T; Zubillaga M
Acta Physiol Pharmacol Ther Latinoam; 1998; 48(4):175-90. PubMed ID: 9914807
[TBL] [Abstract][Full Text] [Related]
55. Surfactant replacement therapy for preterm and term neonates with respiratory distress.
Polin RA; Carlo WA; ;
Pediatrics; 2014 Jan; 133(1):156-63. PubMed ID: 24379227
[TBL] [Abstract][Full Text] [Related]
56. Intrabronchial surfactant application in cases of inhalation injury: first results from patients with severe burns and ARDS.
Pallua N; Warbanow K; Noah EM; Machens HG; Poets C; Bernhard W; Berger A
Burns; 1998 May; 24(3):197-206. PubMed ID: 9677021
[TBL] [Abstract][Full Text] [Related]
57. Tracheal acid or surfactant instillation raises alveolar surface tension.
Nguyen TL; Perlman CE
J Appl Physiol (1985); 2018 Nov; 125(5):1357-1367. PubMed ID: 29771610
[TBL] [Abstract][Full Text] [Related]
58. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
[TBL] [Abstract][Full Text] [Related]
59. [Pathogenesis and target therapy of acute respiratory distress syndrome].
Moroz VV; Vlasenko AV; Golubev AM
Anesteziol Reanimatol; 2014; 59(4):45-52. PubMed ID: 25549486
[TBL] [Abstract][Full Text] [Related]
60. Beneficial effect of exogenous surfactant in infants suffering acute respiratory distress syndrome after cardiac surgery.
Cai J; Su Z; Zhou Y; Shi Z; Xu Z; Liu J; Xu Z; Yang Y
Eur J Cardiothorac Surg; 2011 Sep; 40(3):557-62. PubMed ID: 21371901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
